Table 2 Cell viability of clinical isolate MB-1137 upon the exposure to Citral alone, Azithromycin alone and Citral + Azithromycin in combination at different MIC values.
Time (h) | Untreated control | Cell viability in log10 CFU/ml | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
Citral | Azithromycin | Citral + Azithromycin in combination | ||||||||
MIC | 2MIC | 4MIC | MIC | 2MIC | 4MIC | MIC | 2MIC | 4MIC | ||
0 | 6.47 | 5.13 | 4.94 | 4.87 | 6.29 | 6.21 | 5.62 | 5.39 | 5.98 | 5.17 |
4 | 7.27 | 5.34 | 5.1 | 4.6 | 5.82 | 5.12 | 4.84 | 5.18 | 5.09 | 4.97 |
8 | 8.9 | 4.83 | 4.46 | 3.83 | 5.17 | 4.14 | 3.4 | 4.46 | 4.19 | 3.2 |
16 | 10.1 | 4.64 | 4.12 | 3.24 | 4.83 | 3.3 | 3.1 | 3.21 | 2.9 | 2.3 |
24 | 12.24 | 4.42 | 3.84 | 2.9 | 4.24 | 2.94 | 2.4 | 2.94 | 2.1 | 1.7 |
